All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11510%2F21%3A10438123" target="_blank" >RIV/00216208:11510/21:10438123 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/21:10438123

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V4lEptO.TO" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=V4lEptO.TO</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.rehab.2021.101545" target="_blank" >10.1016/j.rehab.2021.101545</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Extracorporeal shock wave therapy for treating dyspareunia: A prospective, randomized, double-blind, placebo-controlled study

  • Original language description

    Background: Dyspareunia is a genital pain during or after penile-vaginal sexual intercourse. It is a painful spasm of the pelvic muscles that partly or entirely disables vaginal penetration. Objectives: We examined the effect of extracorporeal shock wave therapy (ESWT) on idiopathic non organic dyspareunia in women. A prospective, randomized, double-blind, placebo-controlled study was conducted. Methods: The study included 62 women who reported dyspareunia. Patients in the treatment and placebo groups received ESWT perineally weekly for 4 consecutive weeks; placebo patients received placebo stand-off treatment. The grade of dyspareunia was estimated by using the Marinoff Dyspareunia Scale and subjective pain intensity on a visual analog scale (VAS) before and after treatment. Follow-ups were conducted 1, 4 and 12 weeks after the final ESWT session. Results: The study included 61 women. The treatment but not placebo group differed by the Marinoff Dyspareunia Scale and VAS. Differences before and after treatment within groups were all P &lt; 0.001 and between groups, P &lt; 0.001. Pain reduction was always &gt; 30%. The effect sizes were both large: Marinoff 0.825 and VAS 0.883. Conclusions: ESWT significantly reduced subjective pain in our women treated for dyspareunia.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30214 - Obstetrics and gynaecology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Annals of Physical and Rehabilitation Medicine

  • ISSN

    1877-0657

  • e-ISSN

  • Volume of the periodical

    64

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    FR - FRANCE

  • Number of pages

    5

  • Pages from-to

    101545

  • UT code for WoS article

    000741054400005

  • EID of the result in the Scopus database

    2-s2.0-85111231470